A cohort of 165 adult T-ALL treated prospectively in the GRAALL (Group for Research in Adult Acute Lymphoblastic Leukaemia) trial was split into TAL1 expression quartiles, and compared for disease-free (DFS) and overall survival (OS). This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.